WHO ICTRP trial
A study to evaluate the effectiveness and safety of Apremilast in subjects with…
EUCTR2013-001590-25-HU · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2013-001590-25-HU |
|---|---|
| Public title | A study to evaluate the effectiveness and safety of Apremilast in subjects with active psoriatic arthritis |
| Scientific title | A PHASE 3B, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY AND SAFETY OF APREMILAST (CC-10004) MONOTHERAPY IN SUBJECTS WITH ACTIVE PSORIATIC ARTHRITIS |
| Primary sponsor | Celgene Corporation |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): yes Therapeutic use (Phase IV): no |
| Countries | United States;Estonia;Czech Republic;Hungary;Canada;Spain;Romania;Australia;South Africa;Russian Federation;New Zealand |
| Conditions | Psoriatic Arthritis MedDRA version: 16.1 Level: LLT Classification code 10037160 Term: Psoriatic arthritis System Organ Class: 100000004859 ;Therapeutic area: Diseases [C] - Musculoskeletal Diseases [C05] |
| Interventions | Product Name: Apremilast Product Code: CC-10004 Pharmaceutical Form: Tablet INN or Proposed INN: Apremilast CAS Number: 608141-41-9 Current Sponsor code: CC-10004 Concentration unit: mg milligram(s) Concentration type: equal Concentration… |
| Registration date | Jan 8, 2013 |
| Target size | 298 |
| Secondary IDs | CC-10004-PSA-006 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: